Few questions regarding the use of Mdivi-1 for mitochondrial autophagy inhibition in C57BL/6 mice:

  • I plan to use Mdivi-1 to inhibit mitochondrial autophagy in C57BL/6 mice, but I couldn’t find literature with specific dosing schedules, concentrations, or administration routes. Could anyone share a suitable dosing protocol?
  • Before Mdivi-1 treatment, I will use MPTP at 25 mg/kg by intraperitoneal injection for 7 days to establish a Parkinson’s disease model in C57BL/6 mice. Would the combination of these two drugs increase the mortality risk in mice?
  • When inhibiting mitochondrial autophagy with Mdivi-1, is there a possibility of spontaneous recovery? If we intervene for 2 weeks after Mdivi-1 administration, could the suppressed mitochondrial autophagy function recover after those 2 weeks?
  • More Lucian Miles's questions See All
    Similar questions and discussions